Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral prednisolone versus partial endodontic treatment for pain relief in acute irreversible pulpitis
2015-002485-24Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisolone in irreversible pulpitis (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jun 2015; status: completed.
02
Drugs
prednisolone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on 2015-002485-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002485-24.